ALB and endometrial cancer: The PNI, calculated as 10 × serum albumin (g/dL) + (0.005 × total lymphocyte count/mm3), is associated with increased recurrence risk and shorter survival in breast, prostate, and endometrial cancers [49,50,51,52].